|
1
|
Nishimura N, Uemura T, Iwamoto K and Naora
K: Change in tolbutamide permeability in rat jejunum and Caco-2
cells by Sho-saiko-to (Xiao Chai Hu Tang), a Chinese traditional
medicine. J Pharm Pharmacol. 62:651–657. 2010.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Li JX, Cao Y, Zhang YW and Yang L:
Analysis of disease spectrum of Xiaochaihu decoction. J China Pres
Drug. 16:102–103. 2018.(In Chinese).
|
|
3
|
Chinese Pharmacopoeia Commission:
Pharmacopoeia of the People's Republic of China: One. Beijing:
China Medical Science Press, 2015: 574-576.
|
|
4
|
Liu CG and Du DH: Effects of Xiaochaihu
decoction combined with Lansoprazole on reflux esophagitis. Contemp
Med. 21:157–158. 2015.
|
|
5
|
Li WJ: Evaluation of the efficacy of
Xiaochaihu decoction in the treatment of angina pectoris. Res
Integr Tradit Chin West Med. 8:41–42. 2016.(In Chinese).
|
|
6
|
Lin JB, Zhang YG and Lin PJ: To analyze
the clinical effect of Xiaochaihu decoction combined with entecavir
on chronic hepatitis B. Guide China Med. 15:204–205. 2016.(In
Chinese).
|
|
7
|
Palleria C, Di Paolo A, Giofrè C, Caglioti
C, Leuzzi G, Siniscalchi A, De Sarro G and Gallelli L:
Pharmacokinetic drug-drug interaction and their implication in
clinical management. J Res Med Sci. 18:601–610. 2018.
|
|
8
|
Nishimura N, Uemura T, Iwamoto K and Naora
K: Effects of Sho-saiko-to on the pharmacokinetics and
pharmacodynamics of tolbutamide in rats. J Pharm Pharmacol.
50:231–236. 1998.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Ohnishi N, Okada K, Yoshioka M, Kuroda K,
Nagasawa K, Takara K and Yokoyama T: Studies on interactions
between traditional herbal and western medicines. V. Effects of
Sho-saiko-to (Xiao-Cai-Hu-Tang) on the pharmacokinetics of
carbamazepine in rats. Biol Pharm Bull. 25:1461–1466.
2002.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Zhou Y, Chu XM, Ling SS, Cai WM and Wang
QW: Effects of oral administration of Xiaochaih granule on whole
blood cyclosporin A concentration in kidney transplantation
patients. Chin J Hosp Pharm. 19:713–714. 1999.(In Chinese).
|
|
11
|
Khojasteh SC, Driscoll JP, Jackson KD,
Miller GP, Mitra K, Rietjens IMCM and Zhang D: Novel advances in
cytochrome p450 research. Drug Discov Today. 16:793–799.
2011.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Pillai VC, Strom SC, Caritis SN and
Venkataramanan R: A sensitive and specific Cyp cocktail assay for
the simultaneous assessment of human cytochrome p450 activities in
primary cultures of human hepatocytes using LC-MS/MS. J Pharm
Biomed Anal. 74:126–132. 2013.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Zanger UM and Schwab M: Cytochrome p450
enzymes in drug metabolism: Regulation of gene expression, enzyme
activities, and impact of genetic variation. Pharmacol Ther.
138:103–141. 2013.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Zanger UM, Turpeinen M, Klein K and Schwab
M: Functional pharmacogenetics/genomics of human cytochromes p450
involved in drug biotransformation. Anal Bioanal Chem.
392:1093–1108. 2008.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Xiu LL, Yu X, Liu DN, Wang SR, Liu HY,
Chen SH and Chen F: Effects of different species of sargassum and
radix Glycyrrhizae in Haizao Yuhu decoction on cytochrome P450 in
goiter rats. China J Trad Chin Med Pharm. 32:2020–2025. 2017.(In
Chinese).
|
|
16
|
Cai H, Zhuang YS, Liu X and Cai BC:
Orthogonal optimization of extraction technology of Xiaochaihu
decoction. J Chin Med Mater. 35:2036–2039. 2012.(In Chinese).
|
|
17
|
Li J, Xie M and Gan Y: Effect of
Xiaochaihu decoction and different herbal formulation of component
on inhibiting H22 liver cancer in mice and enhancing immune
function. Zhongguo Zhong Yao Za Zhi. 33:1039–1044. 2008.PubMed/NCBI(In Chinese).
|
|
18
|
Wu FR, Ning LJ and Zhou R: Protective
effect of Xiaochaihu decoction chemical hepatic fibrosis in mice.
Chin J Clin Pharm Ther. 25:481–488. 2020.(In Chinese).
|
|
19
|
Lan X, Tang FS, Chen ZG, Zhang Y, Wang W
and Zhou XM: Determination of baicalin in Xiaochaihu decoction by
HPLC. J Zunyi Med Univ. 38:435–438. 2015.(In Chinese).
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C (T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Zhao F, Tao W, Shang Z, Zhang W, Ruan J,
Zhang C, Zhou L, Aiello H, Lai H and Qu R: Facilitating granule
cell survival and maturation in dentate gyrus with Baicalin for
antidepressant therapeutics. Front Pharmacol.
11(556845)2020.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Yang F, Feng C, Yao Y, Qin A, Shao H and
Qian K: Antiviral effect of baicalin on Marek's disease virus in
CEF cells. BMC Vet Res. 16(371)2020.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Li F, Wang WQ and You PJ: Advances in
extraction technology of flavonoids from radix astragali. Mod Chin
Med. 12:5–9. 2010.(In Chinese).
|
|
24
|
Niemi M, Backman JT, Fromm MF, Neuvonen PJ
and Kivistö KT: Pharmacokinetic interactions with rifampicin:
Clinical relevance. Clin Pharmacokinet. 42:819–850. 2003.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Huang SM, Temple R, Throckmorton DC and
Lesko LJ: Drug interaction studies: Study design, data analysis,
and implications for dosing and labeling. Clin Pharmacol Ther.
81:298–304. 2007.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Mo CK, Xie YR, Chen YL, Huang M and He F:
The effect of Ginkgolide A on the expression of CYP450mRNA by
application of human primary hepatocyte. Pharm Today. 29:79–82.
2019.(In Chinese).
|
|
27
|
Li Q, Zhen YQ, Cao WL, Gao L, Wang YC,
Zhang XJ and Niu LY: Effects of saikosaponins and total glucosides
of paeony on CYP450 enzyme activity and liver function of rat liver
microsomes. Chin Tradit Pat Med. 4:3025–3028. 2019.(In
Chinese).
|
|
28
|
He M, Huang RB and Liu Z: Effects of
rifampicin on cytochrome P450 superfamily and related drugs. China
Pharm. 17:1664–1666. 2006.(In Chinese).
|
|
29
|
Rae JM, Johnson MD, Lippman ME and
Flockhart DA: Rifampin is a selective, pleiotropic inducer of drug
metabolism genes in human hepatocytes: Studies with cDNA and
oligonucleotide expression arrays. J Pharmacol Exp Ther.
299:849–857. 2001.PubMed/NCBI
|
|
30
|
Takeda K, Watanabe J, Inoue K and Kanamura
S: Rifampicin suppresses hepatic cyp2e1 expression and minimizes
DNA injury caused by carbon tetrachloride in perivenular
hepatocytes of mice. Alcohol Clin Exp Res. 24 (Suppl 4):87S–92S.
2000.PubMed/NCBI
|
|
31
|
Yue J, Peng RX, Yang J, Kong R and Liu J:
CYP2E1 mediated isoniazid-induced hepatotoxicity in rats. Acta
Pharmacol Sin. 25:699–704. 2004.PubMed/NCBI
|
|
32
|
Wu S, Yang HL, Li H and Sun ZX:
Prohibitive effect of processed polygonum multiflorum on CYP1A2
activities and mRNA expressions of rats. World Chin Med.
11:475–478-482. 2012.(In Chinese).
|
|
33
|
Pragyan P, Kesharwani SS, Nandekar PP,
Rathod V and Sangamwar AT: Predicting drug metabolism by CYP1A1,
CYP1A2, and CYP1B1: Insights from MetaSite, molecular docking and
quantum chemical calculations. Mol Divers. 18:865–878.
2014.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Zhou SF, Wang B, Yang LP and Liu JP:
Structure, function, regulation and polymorphism and the clinical
significance of human cytochrome P4501A2. Drug Metab Rev.
42:268–354. 2010.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Saruwatari J, Nakagawa K, Shindo J, Nachi
S, Echizen H and Ishizaki T: The in-vivo effects of sho-saiko-to, a
traditional Chinese herbal medicine, on two cytochrome P450 enzymes
(1A2 and 3A) and xanthine oxidase in man. J Pharm Pharmacol.
55:1553–1559. 2003.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Wei LY, Zhang YJ, Wei BH, Ye J, Yang XY
and Sun GX: Effects of Coptis chinensis Franch, Scutellaria
baicalensis Georgi and their compatibility on five CYP450
subenzymes in rat liver microsomes. China J Chin Mater Med.
38:1426–1429. 2013.PubMed/NCBI(In Chinese).
|
|
37
|
Yao YC, Ni J, Han J, Feng LJ and Yan L:
Effects of Scutellaria extract on cytochrome P450 enzymes. Chin J
Exp Tradit Med Formul. 18:202–205. 2012.(In Chinese).
|
|
38
|
Tian S, He GR, Gao M, Sun JL, Wang FB and
Gui GH: Drug interaction potential of oral baicalein on metabolic
enzymes in rats. Chin J New Drug. 21:2230–2234+2301. 2012.(In
Chinese).
|
|
39
|
Huang K, Liu ZH and He Q: Inhibition of
Baicalin on activity of cytochrome P450 enzyme in rat and human
liver microsomes. Chin J Exp Tradit Med Formul. 22:20–23. 2016.(In
Chinese).
|
|
40
|
He YJ, Shi SY, Jin KT and Gao Y: The
modulation effect of Glycyrrhiza in combination with Euphorbia
pekinensis, Euphorbia kansui, and Daphne genkwa on the enzyme
activity of CYP1A2 in rat livers. Chin Remed Clin. 7:278–280.
2016.(In Chinese).
|
|
41
|
Xiao CR, Wang YG, Dai FG, Ma ZC, Tan HL
and Gao Y: The effect of aconitum coadministration with lilac
daphne on cytochrome P450 in rat liver. Chin J Exper Tradit Med
Formul. 12:48–50. 2006.(In Chinese).
|
|
42
|
Nose M, Tamura M, Ryu N, Mizukami H and
Ogihara Y: Sho-saiko-to and Saiko-keisi-to, the traditional Chinese
and Japanese herbal medicines, altered hepatic drug-metabolizing
enzymes in mice and rats when administered orally for a long time.
J Pharm Pharmacol. 55:1419–1426. 2003.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Wang YH, Qi JF and Lin M: Effect of total
saikosaponins on the intestinal first-pass effect and liver
Cyp3a,Cyp2el. Chin J Clin Pharm Ther. 16:740–748. 2011.(In
Chinese).
|
|
44
|
Cheng Y, Huang Y, Tian Y, Xu L, Liu GQ and
Zhang ZJ: Assessment of the effects of Radix Bupleuri and
vinegar-baked Radix Bupleuri on cytochrome 450 activity by a
six-drug cocktail approach. Chin J Nat Med. 11:302–308.
2013.PubMed/NCBI View Article : Google Scholar : (In Chinese).
|
|
45
|
Ingelman-Sundberg M: Genetic polymorphisms
of cytochrome P450 2D6 (CYP2D6): Clinical consequences,
evolutionary aspects and functional diversity. Pharmacogenomics J.
5:6–13. 2005.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Kawakami M, Takenoshita-Nakaya S, Takeba
Y, Nishimura Y, Oda M, Watanabe M, Ohta Y, Kobayashi S, Ohtsubo T,
Kobayashi S, et al: Evaluation of CYP2D6 protein expression and
activity in the small intestine to determine its metabolic
capability in the Japanese population. Biol Pharm Bull.
40:1344–1351. 2017.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Zhou SF, Di YM, Chan E, Du YM, Chow VD,
Xue CC, Lai X, Wang JC, Li CG, Tian M and Duan W: Clinical
pharmacogenetics and potential application in personalized
medicine. Curr Drug Metab. 9:738–784. 2008.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Dai GF, Luo R, Wang YG, Xia CY, Tan HL,
Xiao CR, Zhao YH and Gao Y: Compatible effects of euphorbia and
glycyrrhiza on CYP2E1 expression and activity in rat liver. J Third
Mil Med Univ. 27:742–744. 2009.(In Chinese).
|
|
49
|
Liu MC, Meng QQ, Cui JH and Li JS: Recent
research progress on the CYP1B1 inhibitors. Prog Mod Biomed.
17:4190–4196. 2017.(In Chinese).
|
